{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T19:17:01Z","timestamp":1774725421347,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.clinre.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T10:16:08Z","timestamp":1561630568000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The effect of maternal use of telbivudine on neonatal CD4+CD25+ regulatory T cells for the prevention of mother-to-child transmission of hepatitis B virus"],"prefix":"10.1016","volume":"44","author":[{"given":"Xinyuan","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zonglin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinre.2019.06.004_bib0120","first-page":"92","article-title":"Virus infection during pregnancy: transmission and prevention","volume":"3","author":"Navabakhsh","year":"2011","journal-title":"Middle East J Digest Dis"},{"issue":"7","key":"10.1016\/j.clinre.2019.06.004_bib0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","article-title":"Global control of hepatitis B virus infection","volume":"2","author":"Kao","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.clinre.2019.06.004_bib0130","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","article-title":"Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers","volume":"19","author":"Zou","year":"2012","journal-title":"J Vir Hepat"},{"issue":"8","key":"10.1016\/j.clinre.2019.06.004_bib0135","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.25047","article-title":"Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China","volume":"15","author":"Yang","year":"2018","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.clinre.2019.06.004_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"12","key":"10.1016\/j.clinre.2019.06.004_bib0145","first-page":"885","article-title":"[The effect of telbivudine on peripheral blood CD4+CD25+ regulatory T cells and its significance in patients with chronic hepatitis B]","volume":"16","author":"Pan","year":"2008","journal-title":"Chinese Jr Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2019.06.004_bib0150","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4\u223c+CD25\u223c(high) regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/j.clinre.2019.06.004_bib0155","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jvh.12863","article-title":"The immunosuppressive effects of CD4+CD25+regulatory T cells on dendritic cells in patients with chronic hepatitis B","volume":"25","author":"Zhou","year":"2018","journal-title":"J Viral Hepat"},{"issue":"38","key":"10.1016\/j.clinre.2019.06.004_bib0160","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1016\/j.vaccine.2012.06.063","article-title":"Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis","volume":"30","author":"Seyed Hossein Aalaei-Andabili","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.clinre.2019.06.004_bib0165","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fimmu.2017.01142","article-title":"Dynamic perturbations of CD4 and CD8T Cell receptor repertoires in chronic hepatitis B patients upon oral antiviral therapy","volume":"8","author":"Ying","year":"2017","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/j.clinre.2019.06.004_bib0170","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/hep.27323","article-title":"Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections","volume":"61","author":"Barbara","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2019.06.004_bib0175","first-page":"9","article-title":"The guideline of prevention and treatment for chronic hepatitis B (2010 version)","volume":"01","author":"Chinese Society of Hepatology, Chinese Society of Infectious Diseases C.M.A.","year":"2011","journal-title":"Zhongguo Bingdubing Zazhi"},{"issue":"11","key":"10.1016\/j.clinre.2019.06.004_bib0180","first-page":"813","article-title":"The effects of telbivudine on T lymphocyte subsets in pregnancy with hepatitis B virus","volume":"25","author":"Wang","year":"2016","journal-title":"Prog Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clinre.2019.06.004_bib0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.06.004_bib0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ni1181","article-title":"Natural regulatory T cells in infectious disease","volume":"6","author":"Belkaid","year":"2005","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.clinre.2019.06.004_bib0195","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.20649","article-title":"Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection","volume":"41","author":"Stoop","year":"2010","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.clinre.2019.06.004_bib0200","first-page":"831","article-title":"[Association between CD4+CD25+Foxp3+ regulatory T cells and serum transforming growth factor beta 1 in patients with chronic hepatitis B]","volume":"17","author":"Yang","year":"2009","journal-title":"Zhonghua gan zang bing za zhi"},{"issue":"1","key":"10.1016\/j.clinre.2019.06.004_bib0205","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","article-title":"Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B","volume":"177","author":"Dongping","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.clinre.2019.06.004_bib0210","doi-asserted-by":"crossref","unstructured":"Zheng Y, Huang Z, Chen X, Tian Y, Tang J, Zhang Y, et al. Effects of telbivudine treatment on the circulating CD4+ T-cell subpopulations in chronic hepatitis B patients. 2012;2012(6):789859.","DOI":"10.1155\/2012\/789859"},{"issue":"3","key":"10.1016\/j.clinre.2019.06.004_bib0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/v9030056","article-title":"Complete and incomplete hepatitis b virus particles: formation, function, and application","volume":"9","author":"Hu","year":"2017","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.clinre.2019.06.004_bib0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0168-8278(03)80765-1","article-title":"Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies","volume":"38","author":"Hou","year":"2003","journal-title":"Jr Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2019.06.004_bib0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1651-2227.2007.00038.x","article-title":"e antigen positive mother hepatitis B e antigen long persistence in her non-infected baby","volume":"96","author":"Selton","year":"2007","journal-title":"Acta Peadiatrica"},{"issue":"5","key":"10.1016\/j.clinre.2019.06.004_bib0230","first-page":"700","article-title":"Immunological mechanisms of hepatitis B virus persistence in newborns","volume":"138","author":"Trehanpati","year":"2013","journal-title":"Indian Jr Med Res"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119301299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119301299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:29:27Z","timestamp":1761895767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740119301299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2210740119301299"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2019.06.004","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of maternal use of telbivudine on neonatal CD4+CD25+ regulatory T cells for the prevention of mother-to-child transmission of hepatitis B virus","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}